MMJ BioPharma Cultivation and Native American Tribe Moving Forward With Marijuana DEA Application
ST. PETERSBURG, FL / ACCESSWIRE / July 14, 2019 / MMJ BioPharma Cultivation has applied for a DEA Schedule-I Bulk...
user
Theramed Health Corporation Announces Subsidairy Name Change to EGF Health Holdings Corp. and Debt Settlements
VANCOUVER, BC / ACCESSWIRE / July 12, 2019 / Theramed Health Corporation (CSE: TMED, OTCQB: EVAHF) (the “Company”) is pleased...
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019
HACKENSACK, NJ / ACCESSWIRE / July 12, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of...
Hemogenyx Pharmaceuticals PLC Announces CDX Patent Application
LONDON, UK / ACCESSWIRE / July 12, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has filed a...
G4 By Golpa Launches Smile Revolution National Dental Implant Promotion
Twelve Lucky Monthly Winners To Receive FREE G4 By Golpa Dental Implant Procedures LAS VEGAS, NV / ACCESSWIRE / July...
Complimentary 30-Minute Skin Analysis is Now Available at Bruggeman Plastic Surgery & Aesthetics
First-Time Patients will Receive a Skin Analysis that Addresses Common Skin Concerns PEORIA, AZ / ACCESSWIRE / July 11, 2019...
Jaguar Health’s Wholly Owned Subsidiary, Napo Pharmaceuticals, Inc., Commits to Support Study Evaluating the Effect of Crofelemer on Patients With Chronic Idiopathic Diarrhea
SAN FRANCISCO, CA / ACCESSWIRE / July 11, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), a...
International Cannabrands Announces La Vida Verde’s Expansion into Nevada Through Long-Term Licensing Agreement with Flower One
The deal promises to bring organic cannabis edibles and tinctures to Nevada through strategic partnershipDENVER, COLORADO / ACCESSWIRE / July...
StageZero Life Sciences Announces First Closing of CDN $3.7 Million Private Placement
TORONTO, ON / ACCESSWIRE / July 11, 2019 / StageZero Life Sciences Ltd (TSX: SZLS) ("StageZero" or the "Company") today...
YIELD GROWTH Announces Definitive Agreement for Exclusive Distribution of Urban Juve Products in Greece and Cyprus
VANCOUVER, BC / ACCESSWIRE / July 11, 2019 / The Yield Growth Corp. (OTCQB:BOSQF) (CSE:BOSS) (Frankfurt:YG3) is pleased to announce...
Intellipharmaceutics Announces Second Quarter 2019 Results
TORONTO, ON / ACCESSWIRE / July 10, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (“Intellipharmaceutics” or the...
Co2 GRO Inc. Announces the Appointment of Dr. Matthew Julius as Chief Science Officer
TORONTO, ON / ACCESSWIRE / July 10, 2019 Toronto based CO2GRO Inc. ("GROW") (TSX-V: GROW, OTCQB: BLONF, Frankfurt: 4021) is...
Nuzuna Zone Fitness Welcomes Thomas O’Neill to its Board
COSTA MESA, CA / ACCESSWIRE / July 10, 2019 / Nuzuna Zone Fitness is pleased to announce that Thomas O’Neil...
Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial
Positive early outcomes in complex in-stent restenosis cases with few therapeutic options REDWOOD CITY, CA / ACCESSWIRE / July 10,...
International Cannabrands Announces Financing Engagement Co-Led by Gravitas Securities and Canaccord Genuity
Not for Dissemination to United States Newswire Services or for Dissemination in the United States CALGARY, AB / ACCESSWIRE /...
Calidi Biotherapeutics Announces Global Oncolytic Virus-based Immunotherapy License to VetStem Biopharma for its Pioneering Treatment of Cancer in the Veterinary Field
SAN DIEGO, CA / ACCESSWIRE / July 10, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront...
Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year
Global, unaudited sales of HEMOBLAST(TM) Bellows for the first half of 2019 were EUR1.4 million - on track to achieve...
Kadmon Doses First Patient in Phase 2 Clinical Trial of KD025 in Systemic Sclerosis
NEW YORK, NY / ACCESSWIRE / July 9, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that the first...
StageZero Life Sciences Expands Salesforce Through Collaboration with Coastal Medical
TORONTO, ON / ACCESSWIRE / July 9, 2019 / StageZero Life Sciences ("StageZero" or the "Company") (TSX: SZLS) today announced...
AiCuris and Lysando Join Forces in the Fight Against Antimicrobial Resistance
Cooperation focused on the joint development and optimization of human anti-infective drug candidates against gram-negative and gram-positive bacteria in relevant...